Ecaterina E Ileana Dumbrava

机构：The University of Texas MD Anderson Cancer Center · ORCID：0000-0002-1959-0536

发表论文 388 篇 · 总被引 2692 次 · h-index 24

代表论文

Phase 1 Study of Rezatapopt, a p53 Reactivator, in TP53 Y220C–Mutated Tumors (2026 · New England Journal of Medicine · 被引 24)
Initial phase 1 study results of NT-175 engineered T-cell therapy in TP53 R175H–mutated unresectable advanced solid tumors. (2026 · Journal of Clinical Oncology · 被引 1)
Phase 1/1b open-label, first-in-human study of HER2×CD3×CD28 trispecific T-cell engager (SAR443216) in participants with R/R HER2-expressing solid tumors (2026 · Journal for ImmunoTherapy of Cancer)
Outcomes of early-onset vs average-onset colorectal cancer patients on phase I matched and non-matched therapies (2026 · npj Precision Oncology)
Supplementary Table S5 from Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors (2026)
Supplementary Figure S4 from Comprehensive Genomic and Transcriptomic Analysis to Guide Therapy for Patients with Metastatic Solid Tumors (2026)